Navigation Links
Sangamo BioSciences Reports 2007 Fourth Quarter and Year-End Financial Results
Date:2/5/2008

arterly Reports on Form 10-Q as filed with the Securities and Exchange Commission. Forward-looking statements contained in this announcement are made as of this date and will not be updated. Contact

SELECTED FINANCIAL DATA

(in thousands, except per share data)

(unaudited)

Three Months Ended Twelve Months Ended

December 31, December 31,

2007 2006 2007 2006

Consolidated Statement of

Operations Data:

Revenues $2,767 $2,193 $9,098 $7,885

Operating expenses:

Research and development 7,904 10,057 25,559 21,527

General and administrative 2,470 1,942 8,310 7,087

Total operating expenses 10,374 11,999 33,869 28,614

Loss from operations (7,607) (9,806) (24,771) (20,729)

Interest and other income, net 935 858 3,291 2,865

Net loss $(6,672) $(8,948) $(21,480) $(17,864)

Basic and diluted net loss per

common share $(0.17) $(0.26) $(0.58) $(0.55)

Shares used in computing basic and

diluted net loss per common share 40,226 34,098 37,355 32,502

CONSOLIDATED CONDENSED BALANCE SHEET DATA

December 31, December 31,

2007 2006

Cash, cash equivalents, and

investments 81,412 53,975

Total assets 83,900 55,780

Total stockholders' equity 72,122 48,705


'/>"/>
SOURCE Sangamo BioSciences, Inc.
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Sangamo BioSciences Announces Completion of Enrollment of Phase 2 Clinical Trial of ZFP Therapeutic for Diabetic Neuropathy
2. Sangamo BioSciences and Sigma-Aldrich Announce Nature Biotechnology Study Demonstrating Zinc Finger Technology for Modification of Human Stem Cells
3. Neurocrine Biosciences Reports Fourth Quarter and Year-End 2007 Results
4. CeloNova BioSciences Introduces a New Class of Coronary Stent: The CATANIA(TM) Coronary Stent System with NanoThin Polyzene(R)-F
5. CeloNova BioSciences Announces Positive Results from European Study of Embozene(TM) Microspheres for Treatment of Uterine Fibroids
6. Epiphany Biosciences Reports Initiation of Phase 2 Study of Valomaciclovir for the Treatment of Acute Infectious Mononucleosis
7. Ardea Biosciences, Inc. Announces New Clinical Development Program Directed Toward the Treatment of Gout
8. Epiphany Biosciences Reports Initiation and Enrollment in Valomaciclovir Study for Shingles
9. Regado Biosciences Presents Early Stage Clinical Data for REG1 Anticoagulation System at American Heart Association 2007 Scientific Sessions
10. Regado Biosciences Presents Positive Data From REG1 Anticoagulation System Phase Ic Study at American Heart Association 2007 Scientific Sessions
11. Regado Biosciences Initiates Phase IIa Clinical Study of REG1 Anticoagulation System
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/16/2013)... and MECHELEN, Belgium , May 17, ... (NYSE: ABBV ) announced today an extension ... disease.  Galapagos will fund and complete a Phase 2 ... rapid progression into Phase 3.  Upon successful completion of ... Galapagos $50 million.  The terms of the collaboration extension ...
(Date:5/16/2013)... , May 16, 2013  HeartWare International, Inc. (NASDAQ: ... of less invasive, miniaturized circulatory support technologies that are revolutionizing ... Doug Godshall is scheduled to present ... EDT on Monday, May 20, 2013.  The conference is being ... A live webcast of the Company,s presentation at ...
(Date:5/16/2013)... , May 16, 2013 ... in the U.S. to access the widely-used OrthoView digital ... PC and Internet connection to get started. ... software for over 10 years, is dedicated to enabling ... with digital x-ray images, when printed film is unavailable. ...
Breaking Medicine Technology:AbbVie and Galapagos Extend GLPG0634 Collaboration to Include Crohn's Disease 2AbbVie and Galapagos Extend GLPG0634 Collaboration to Include Crohn's Disease 3AbbVie and Galapagos Extend GLPG0634 Collaboration to Include Crohn's Disease 4AbbVie and Galapagos Extend GLPG0634 Collaboration to Include Crohn's Disease 5AbbVie and Galapagos Extend GLPG0634 Collaboration to Include Crohn's Disease 6HeartWare Presentation At The 2013 UBS Global Healthcare Conference To Be Webcast 2OrthoView Announces the U.S. Launch of a New, Subscription-based, Digital Planning and Templating Solution for Individual Orthopaedic Surgeons 2
... Intra-Cellular Therapies, Inc. (ITI),today announced it has initiated ... using its drug candidate ITI-722. ITI-722 acts predominantly,as ... important new,approach to the treatment of SMI. Because ... modulatory activities, ITI believes, ITI-722 can be,used not ...
... Research Is a Winning Pursuit, WASHINGTON, Dec. ... L. Trull President, Foundation for Biomedical,Research:, Biomedical ... of pursuit" in 1980 earned Mario Capecchi a ... setback, the Harvard-educated genetics professor,persisted toward his goal. ...
Cached Medicine Technology:Intra-Cellular Therapies Initiates Phase 2 Clinical Trial for Sleep Maintenance Insomnia 2Intra-Cellular Therapies Initiates Phase 2 Clinical Trial for Sleep Maintenance Insomnia 3Intra-Cellular Therapies Initiates Phase 2 Clinical Trial for Sleep Maintenance Insomnia 4Nobel Prize-Winning Discovery 2Nobel Prize-Winning Discovery 3
(Date:5/19/2013)... May 19, 2013 The Pradaxa lawyers ... Conference was recently convened for hundreds of Pradaxa ... now underway in U.S. District Court, Southern District of ... website on May 14th, the Conference addressed the status ... reported during the Conference that Defendants submitted a list ...
(Date:5/19/2013)... The Fat Loss Code program developed by Shawn Stevenson covers ... get in shape, and gain a healthy life regardless of ... a natural fat loss system that provides people with effective ... loss diet program claimed that The Fat Loss Code is ... fat off long-term. After Shawn Stevenson launched this new body ...
(Date:5/19/2013)... 2013 Exciting new Skin Brushes are ... a great practice known through the ages but is ... dry body brushing, has so many benefits for our ... Beauty®. "We love that circulation and lymphatic systems get ... the skin, is supported through Skin Brushing." , Why ...
(Date:5/19/2013)... Atlanta, GA (PRWEB) May 19, 2013 The ... and 2pm at the Columbus Georgia Convention & Trade Center ... are invited to attend. AMTC auditions are free of charge. ... the starting point for hundreds of successful artists and grads ... new face for European Tombolini , Chris Young - on ...
(Date:5/19/2013)... (PRWEB) May 19, 2013 The Da ... to follow developments in the nation’s first trial involving ... underway in Washington State Superior Court, was filed by ... after he suffered complications in a robot-assisted prostate removal, ... Da Vinci robotic surgery lawsuit alleges those ...
Breaking Medicine News(10 mins):Health News:Pradaxa Lawyers at Bernstein Liebhard LLP Report on Recent Status Conference in Federal Pradaxa Litigation 2Health News:Pradaxa Lawyers at Bernstein Liebhard LLP Report on Recent Status Conference in Federal Pradaxa Litigation 3Health News:Weight Loss Secrets | How “The Fat Loss Code” Helps People Gain A Healthy Life And Get In Shape - Health Review 2Health News:Exciting New Skin Brushes at Sublime Beauty® Bring Health and Beauty Benefits; Celebrities and Models Know the Secret 2Health News:Actors, Models and Talent for Christ Hosting Auditions in Columbus, GA June 1st in Search of Local Talent 2Health News:Da Vinci Surgical Robot Lawyers at Wright & Schulte LLC Note Recent Developments in Da Vinci Robot Lawsuit Trial 2Health News:Da Vinci Surgical Robot Lawyers at Wright & Schulte LLC Note Recent Developments in Da Vinci Robot Lawsuit Trial 3Health News:Da Vinci Surgical Robot Lawyers at Wright & Schulte LLC Note Recent Developments in Da Vinci Robot Lawsuit Trial 4
... researchers looked at the distribution of primary stroke ... national organizations (such as The Joint Commission in ... They found that 24 percent of acute general ... the eight states that have a state-based program ...
... in the brains of patients with Alzheimer disease collude, resulting ... cells, according to new findings published online in Neurobiology ... pathological forms of two proteins, amyloid beta and tau, which ... patients plaques and tangles may work in tandem ...
... Researchers from Boston Medical Center (BMC) and Boston ... use as a risk factor for not receiving all ... in BMJ Open, identify unhealthy substance use ... influenza vaccination. Cancer and influenza ...
... influences decision making on issues whose consequences will only ... the annual Addiction Science Awards at this year,s Intel ... largest science competition for high school students. The Intel ... ceremony Thursday night in Los Angeles. The awards were ...
... Elsevier, the world,s leading publisher of scientific ... India,s first contract research organization, has signed a ... Reaxys for all Syngene researchers. Reaxys will help ... the ever-expanding and highly competitive Indian pharmaceutical, chemical ...
... This release is also available in Chinese on ... the discomfort and pain some people experience while using in-ear ... canal from external sound -- have found not only what ... In two separate papers and a presentation at the 130th ...
Cached Medicine News:Health News:2 defective proteins conspire to impair the nerve cell's 'powerhouse' in Alzheimer's disease 2Health News:2 defective proteins conspire to impair the nerve cell's 'powerhouse' in Alzheimer's disease 3Health News:Study finds unhealthy substance use a risk factor for not receiving some preventive health services 2Health News:Altruistic decision making focus of NIDA's Addiction Science Award 2Health News:Altruistic decision making focus of NIDA's Addiction Science Award 3Health News:Sound safety 2Health News:Sound safety 3Health News:Sound safety 4Health News:Sound safety 5
... This is the only ... counts in patient synovial fluid ... hemocytometer. It is also an ... which may indicate a pathological ...
... is intended as a means ... assay methods used for the ... urine samples. This control is ... This control is supplied as ...
... validates urine dipstick readings by applying the ... plastic dropper tip designed for easy dispensing ... the addition of creatinine and microalbumin. Assay ... results for hCG for early pregnancy detection ...
... Pyrogallol Red Molybdate dye binding ... method for total protein quantitation with ... urine or cerebrospinal fluid (CSF) in ... includes four reagent standards (level 2, ...
Medicine Products: